Now use the power of histochemistry for biomarker identification and drug discovery in cancer. Using our proprietary screen on tumor tissues for identification of putative tumor markers, and potential drugabble targets, we facilitate tumor-specific proteins/pathways identification. One of the important features of Exo-BiDD™ is that it ensures tumor heterogeneity mapping to give you right insight about the expression status of protein-of-interest. Use Exo-BiDD™ for biomarker discovery, druggable target identification, tumor heterogeneity mapping, and for screening of tumor tissue arrays to identify ubiquitous tumor marker.